Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response

Inflammatory or anti-inflammatory? That is the question as far as the acute-phase response and its mediators, the pentraxins, are concerned. Only some ten years ago, the classical or short pentraxin C-reactive protein and the newly discovered long pentraxin PTX3 were considered to exert most of the...

Full description

Saved in:
Bibliographic Details
Main Authors: P. Kunes, Z. Holubcova, M. Kolackova, J. Krejsek
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2012/920517
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849473315898392576
author P. Kunes
Z. Holubcova
M. Kolackova
J. Krejsek
author_facet P. Kunes
Z. Holubcova
M. Kolackova
J. Krejsek
author_sort P. Kunes
collection DOAJ
description Inflammatory or anti-inflammatory? That is the question as far as the acute-phase response and its mediators, the pentraxins, are concerned. Only some ten years ago, the classical or short pentraxin C-reactive protein and the newly discovered long pentraxin PTX3 were considered to exert most of the detrimental effects of acute inflammation, whether microbial or sterile in origin. However, accumulating evidence suggests an at least dichotomous, context-dependent outcome attributable to the pentraxins, if not a straightforward anti-inflammatory nature of the acute-phase response. This paper is focused on the inherent effects of pentraxin 3 in inflammatory responses, mainly in coronary artery disease and in Aspergillus fumigatus infection. Both are examples of inflammatory reactions in which PTX3 is substantially involved; the former sterile, the latter infectious in origin. Apart from different inducing noxae, similarities in the pathogenesis of the two are striking. All the same, the introductory question still persists: is the ultimate impact of PTX3 in these conditions inflammatory or anti-inflammatory, paradoxical as the latter might appear? We try to provide an answer such as it emerges in the light of recent findings.
format Article
id doaj-art-c7d3e2758afc4757a91a2e0c91d3a7b9
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-c7d3e2758afc4757a91a2e0c91d3a7b92025-08-20T03:24:11ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/920517920517Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory ResponseP. Kunes0Z. Holubcova1M. Kolackova2J. Krejsek3Department of Cardiac Surgery, University Hospital and Medical School of Hradec Kralove, Charles University in Prague, 12843 Prague, Czech RepublicDepartment of Cardiac Surgery, University Hospital and Medical School of Hradec Kralove, Charles University in Prague, 12843 Prague, Czech RepublicDepartment of Clinical Immunology and Allergology, University Hospital and Medical School of Hradec Kralove, Charles University in Prague, 12843 Prague, Czech RepublicDepartment of Clinical Immunology and Allergology, University Hospital and Medical School of Hradec Kralove, Charles University in Prague, 12843 Prague, Czech RepublicInflammatory or anti-inflammatory? That is the question as far as the acute-phase response and its mediators, the pentraxins, are concerned. Only some ten years ago, the classical or short pentraxin C-reactive protein and the newly discovered long pentraxin PTX3 were considered to exert most of the detrimental effects of acute inflammation, whether microbial or sterile in origin. However, accumulating evidence suggests an at least dichotomous, context-dependent outcome attributable to the pentraxins, if not a straightforward anti-inflammatory nature of the acute-phase response. This paper is focused on the inherent effects of pentraxin 3 in inflammatory responses, mainly in coronary artery disease and in Aspergillus fumigatus infection. Both are examples of inflammatory reactions in which PTX3 is substantially involved; the former sterile, the latter infectious in origin. Apart from different inducing noxae, similarities in the pathogenesis of the two are striking. All the same, the introductory question still persists: is the ultimate impact of PTX3 in these conditions inflammatory or anti-inflammatory, paradoxical as the latter might appear? We try to provide an answer such as it emerges in the light of recent findings.http://dx.doi.org/10.1155/2012/920517
spellingShingle P. Kunes
Z. Holubcova
M. Kolackova
J. Krejsek
Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response
Mediators of Inflammation
title Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response
title_full Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response
title_fullStr Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response
title_full_unstemmed Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response
title_short Pentraxin 3(PTX 3): An Endogenous Modulator of the Inflammatory Response
title_sort pentraxin 3 ptx 3 an endogenous modulator of the inflammatory response
url http://dx.doi.org/10.1155/2012/920517
work_keys_str_mv AT pkunes pentraxin3ptx3anendogenousmodulatoroftheinflammatoryresponse
AT zholubcova pentraxin3ptx3anendogenousmodulatoroftheinflammatoryresponse
AT mkolackova pentraxin3ptx3anendogenousmodulatoroftheinflammatoryresponse
AT jkrejsek pentraxin3ptx3anendogenousmodulatoroftheinflammatoryresponse